Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.
Oncoimmunology
; 9(1): 1722022, 2020.
Article
in En
| MEDLINE
| ID: mdl-32313716
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hypereosinophilic Syndrome
/
Antineoplastic Agents, Immunological
Type of study:
Observational_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
Oncoimmunology
Year:
2020
Document type:
Article
Affiliation country:
Francia
Country of publication:
Estados Unidos